Mylan

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Mylan and buy or sell other stocks, ETFs, and their options commission-free!

About MYL

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. 

CEO
Heather M. Bresch, MBA
CEOHeather M. Bresch, MBA
Employees
32,000
Employees32,000
Headquarters
Hatfield, Hertfordshire
HeadquartersHatfield, Hertfordshire
Founded
2014
Founded2014
Employees
32,000
Employees32,000

MYL Key Statistics

Market cap
18.38B
Market cap18.38B
Price-Earnings ratio
-3.70
Price-Earnings ratio-3.70
Dividend yield
3.86%
Dividend yield3.86%
Average volume
7.24M
Average volume7.24M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$12.74
52 Week high$12.74
52 Week low
$6.85
52 Week low$6.85

Stock Snapshot

With a market cap of 18.38B, Mylan(MYL) trades at $15.86. The stock has a price-to-earnings ratio of -3.70 and currently yields dividends of 3.9%.

On 2025-12-17, Mylan(MYL) stock opened at —, reached a high of —, and a low of —.

The Mylan(MYL)'s current trading volume is 0, compared to an average daily volume of 7.24M.

During the past year, Mylan(MYL) stock moved between $6.85 at its lowest and $12.74 at its peak.

During the past year, Mylan(MYL) stock moved between $6.85 at its lowest and $12.74 at its peak.

People also own

Based on the portfolios of people who own MYL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.